Do age-associated DNA methylation changes increase the risk of malignant transformation?

BioEssays

Volumn 37, Issue 1, 2015, Pages 20-24

  Wagner, Wolfgang ^a   Weidner, Carola I ^a   Lin, Qiong ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Aging; Cancer; DNA methylation; DNMT3A; Epigenetic; Epimutation; Predictor

Indexed keywords

DNA METHYLTRANSFERASE 3A;

ACUTE GRANULOCYTIC LEUKEMIA; AGE DETERMINATION; AGING; ARTICLE; CANCER CELL; CELL AGING; CHROMATIN; DNA METHYLATION; EPIGENETICS; GENE MUTATION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; RISK FACTOR; CELL TRANSFORMATION; GENETIC EPIGENESIS; GENETICS; NEOPLASM; PATHOLOGY;

AGING; CELL AGING; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS; RISK FACTORS;

EID: 84919458913     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201400063     Document Type: Article

References (42)

1. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, et al. 2013. Signatures of mutational processes in human cancer. Nature 500: 415-21.
2. Jeong M, Sun D, Luo M, Huang Y, et al. 2014. Large conserved domains of low DNA methylation maintained by DNMT3a. Nat Genet 46: 17-23.
3. Jost E, Lin Q, Ingrid WC, Wilop S, et al. 2013. Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia. Leukemia 28: 1227-34.
4. Bork S, Pfister S, Witt H, Horn P, et al. 2010. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9: 54-63.
5. Smith ZD, Meissner A. 2013. DNA methylation: roles in mammalian development. Nat Rev Genet 14: 204-20.
6. Wu H, Zhang Y. 2011. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev 25: 2436-52.
7. Lister R, Mukamel EA, Nery JR, Urich M, et al. 2013. Global epigenomic reconfiguration during mammalian brain development. Science 341: 1237905.
8. Rakyan VK, Down TA, Maslau S, Andrew T, et al. 2010. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 20: 434-9.
9. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, et al. 2010. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res 20: 440-6.
10. Weidner CI, Lin Q, Koch CM, Eisele L, et al. 2014. Aging of blood can be tracked by DNA methylation changes at just three CpG sites. Genome Biol 15: R24.
11. Horvath S. 2013. DNA methylation age of human tissues and cell types. Genome Biol 14: R115.
12. Frobel J, Hemeda H, Lenz M, Abagnale G, et al. 2014. Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Rep 3: 414-22.
13. Bocklandt S, Lin W, Sehl ME, Sanchez FJ, et al. 2011. Epigenetic predictor of age. PLoS One 6: e14821.
14. Koch CM, Wagner W. 2011. Epigenetic-aging-signature to determine age in different tissues. Aging (Albany NY) 3: 1018-27.
15. Hannum G, Guinney J, Zhao L, Zhang L, et al. 2013. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell 49: 359-67.
16. Alisch RS, Barwick BG, Chopra P, Myrick LK, et al. 2012. Age-associated DNA methylation in pediatric populations. Genome Res 22: 623-32.
17. Garagnani P, Bacalini MG, Pirazzini C, Gori D, et al. 2012. Methylation of ELOVL2 gene as a new epigenetic marker of age. Aging Cell 11: 1132-4.
18. Bibikova M, Barnes B, Tsan C, Ho V, et al. 2011. High density DNA methylation array with single CpG site resolution. Genomics 98: 288-95.
19. Hayflick L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614-36.
20. Campisi J. 2013. Aging, cellular senescence, and cancer. Annu Rev Physiol 75: 685-705.
21. Koch CM, Joussen S, Schellenberg A, Lin Q, et al. 2012. Monitoring of cellular senescence by DNA-methylation at specific CpG sites. Aging Cell 11: 366-9.
22. Koch CM, Reck K, Shao K, Lin Q, et al. 2013. Pluripotent stem cells escape from senescence-associated DNA methylation changes. Genome Res 23: 248-59.
23. Finkel T, Serrano M, Blasco MA. 2007. The common biology of cancer and ageing. Nature 448: 767-74.
24. Cruickshanks HA, McBryan T, Nelson DM, Vanderkraats ND, et al. 2013. Senescent cells harbour features of the cancer epigenome. Nat Cell Biol 15: 1495-506.
25. Chen Z, Trotman LC, Shaffer D, Lin HK, et al. 2005. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-30.
26. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, et al. 2005. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-4.
27. Marciniak-Czochra A, Stiehl T, Wagner W. 2009. Modeling of replicative senescence in hematopoietic development. Aging (Albany NY) 1: 723-32.
28. Moore A. 2012. TOR: the ancient link between cancer and ageing? Could ageing and cancer be unified by TOR via the 'compromise' struck between soma and germline at the dawn of multicellular life? BioEssays 34: 443-4.
29. Martins AC. 2011. Change and aging senescence as an adaptation. PLoS One 6: e24328.
30. Kirkwood TB. 2008. Understanding ageing from an evolutionary perspective. J Intern Med 263: 117-27.
31. Zane L, Sharma V, Misteli T. 2014. Common features of chromatin in aging and cancer: cause or coincidence? Trends Cell Biol, DOI: 10.1016/j.tcb.2014.07.001
32. Zhu ZZ, Sparrow D, Hou L, Tarantini L, et al. 2011. Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study. Cancer Causes Control 22: 437-47.
33. Issa JP, Ottaviano YL, Celano P, Hamilton SR, et al. 1994. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536-40.
34. Issa JP, Vertino PM, Boehm CD, Newsham IF, et al. 1996. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci USA 93: 11757-62.
35. Maegawa S, Gough SM, Watanabe-Okochi N, Lu Y, et al. 2014. Age-related epigenetic drift in the pathogenesis of MDS and AML. Genome Res 24: 580-91.
36. Xu Z, Taylor JA. 2014. Genome-wide age-related DNA methylation changes in blood and other tissues relate to histone modification, expression and cancer. Carcinogenesis 35: 356-64.
37. Cancer Genome Atlas Research Network. 2013. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368: 2059-74.
38. Teschendorff AE, West J, Beck S. 2013. Age-associated epigenetic drift: implications, and a case of epigenetic thrift? Hum Mol Genet 22: 7-15.
39. Schoofs T, Rohde C, Hebestreit K, Klein HU, et al. 2013. DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding. Blood 121: 178-87.
40. Schoofs T, Berdel WE, Muller-Tidow C. 2014. Origins of aberrant DNA methylation in acute myeloid leukemia. Leukemia 28: 1-14.
41. Ley TJ, Ding L, Walter MJ, McLellan MD, et al. 2010. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 363: 2424-33.
42. Weidner CI, Walenda T, Lin Q, Wölfler MM, et al. 2013. Hematopoietic stem and progenitor cells acquire distinct DNA-hypermethylation during in vitro culture. Sci Rep 3: 3372.